(Q34551581)

English

GMP-compliant, large-scale expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells in vitro and in vivo

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

GMP-compliant, large-scale expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells in vitro and in vivo (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

12

object named as

Eui-Cheol Shin

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Okjae Lim

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Yuna Lee

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Hyejin Chung

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Jung Hyun Her

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sang Mi Kang

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Mi-young Jung

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Bokyung Min

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Hyejin Shin

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Tae Min Kim

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Dae Seog Heo

10

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Yu Kyeong Hwang

11

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

11 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

e53611

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

copyright license

Creative Commons Attribution 4.0 International

11 January 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543306

7 July 2018

Clinical-grade generation of active NK cells from cord blood hematopoietic progenitor cells for immunotherapy using a closed-system culture process

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543306

7 July 2018

Clinical cancer therapy by NK cells via antibody-dependent cell-mediated cytotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543306

7 July 2018

Helper activity of natural killer cells during the dendritic cell-mediated induction of melanoma-specific cytotoxic T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543306

7 July 2018

Intravital imaging reveals distinct dynamics for natural killer and CD8(+) T cells during tumor regression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543306

7 July 2018

Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543306

7 July 2018

Rituximab (Rituxan).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543306

7 July 2018

Natural killer cell-based immunotherapy in cancer: current insights and future prospects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543306

7 July 2018

Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543306

7 July 2018

Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543306

7 July 2018

Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543306

7 July 2018

Natural killer cell-directed therapies: moving from unexpected results to successful strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543306

7 July 2018

Prospects for the use of NK cells in immunotherapy of human cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543306

7 July 2018

Adoptive immunotherapy for cancer: building on success

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543306

7 July 2018

NK cell recognition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543306

7 July 2018

Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543306

7 July 2018

Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543306

7 July 2018

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543306

7 July 2018

Dendritic cell-based therapy: a review focusing on antigenic selection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543306

7 July 2018

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543306

7 July 2018

Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543306

7 July 2018

Regulation of immune responses through inhibitory receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543306

7 July 2018

Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543306

7 July 2018

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543306

7 July 2018

Biology and clinical relevance of human natural killer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3543306

7 July 2018

Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0053611

21 January 2018

Serial killing of tumor cells by human natural killer cells--enhancement by therapeutic antibodies

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0053611

21 January 2018

Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0053611

21 January 2018

Natural killer cells play a critical role in the immune response following immunization with melanoma-antigen-engineered dendritic cells

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0053611

21 January 2018

Kinetics and organ distribution of allogeneic natural killer lymphocytes transfused into patients suffering from renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0053611

21 January 2018

A new method for in vitro expansion of cytotoxic human CD3-CD56+ natural killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23326467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor

1 reference

https://pubmed.ncbi.nlm.nih.gov/23326467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of monocytes in the expansion of human activated natural killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/23326467

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0053611

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

2013PLoSO...853611L

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34551581&oldid=1971329867"